Sign in

CIK 0001819133

  • Non-accelerated filer
  • Smaller reporting company

Tango Therapeutics, Inc.

Sign in to watch
Ticker
TNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-320-4900
Business address
201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
Former names
BCTG Acquisition Corp.
  1. 4 Grant or award Director acquired 6,250 shares (grant or award)
  2. 4 Grant or award Director acquired 6,250 shares (grant or award)
  3. 4 Grant or award Director acquired 6,250 shares (grant or award)
  4. 4 Grant or award Director acquired 6,250 shares (grant or award)
  5. 4 Open-market sale General Counsel sold 5,330 shares at an average $3.07 ($16,369)
  6. 4 Open-market sale Chief Financial Officer sold 8,232 shares at an average $3.07 ($25,282)
  7. 4 Open-market sale Crystal Adam sold 14,283 shares at an average $3.07 ($43,866)
  8. 4 Open-market sale Chief Executive Officer sold 18,791 shares at an average $3.07 ($57,710)
  9. 4 Grant or award Chief Financial Officer acquired 26,119 shares (grant or award)
  10. 4 Grant or award Crystal Adam acquired 53,015 shares (grant or award)
  11. 4 Grant or award Chief Executive Officer acquired 105,875 shares (grant or award)
  12. 4 Grant or award General Counsel acquired 27,363 shares (grant or award)
  13. 4 Open-market buy Director bought 20,000 shares at an average $3.70 ($74,000)
  14. 4 Open-market sale 10% owner sold 2,700,000 shares at an average $3.12 ($8,435,743)
  15. 4 Open-market sale Boxer Capital Management, LLC sold 3,080,000 shares at $3.14 ($9,671,200)
  16. 4 Open-market sale Boxer Capital Management, LLC sold 633,000 shares at $6.87 ($4,348,710)
  17. 4 Open-market sale Boxer Capital Management, LLC sold 875,000 shares at an average $6.97 ($6,101,250)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale 10% owner sold 67,400 shares at $10.53 ($709,756)
  20. 4 Open-market sale 10% owner sold 75,000 shares at $11.56 ($867,135)

Page 3 of 8 · 156 filings